It would be great if we had a crystal ball to tell us which illnesses we’ll get and how to avoid them. Until we do, the next best thing is to know your risk factors for certain diseases, including ovarian cancer.
A new blood test that detects breast cancer has been discovered by researchers. The non-invasive method will be able to identify breast cancer five years before any clinical signs of the disease appear. During the test, auto-antibodies for the tumor antigens will predict breast cancer presence. Researchers have confirmed that this blood screening method will be ready for clinical use in four to five years’ time.
Early detection of breast cancer can help both patients and doctors prevent its progression. The invention of this advanced screening method adds to the many efforts by researchers to find better ways of fighting the disease, such as the breast cancer vaccine.
All body cells, including cancer cells, produce antigens. When these antigens are exposed to other cells within the body, they cause the immune system to generate auto-antibodies. Tumor-associated antigens indicate that cancer is present. In the same way, when an antigen’s auto-antibody appears, it means that a tumor is present.
During the study:
Researchers built blood panels against the type of blood to be screened. They used a protein microarray for the antibodies linked to tumor-associated antigens in breast cancer tumors. Forty antibodies were tested, with 27 of them not related to breast cancer. Each blood panel was targeted to a subset of antibodies.
The blood samples were from both patients diagnosed with breast cancer and volunteers without the disease. It was observed that breast cancer could induce auto-antibodies on particular tumor-associated antigens. Cancer could be accurately be detected by identifying the autoantibodies in a patient’s blood.
Although the outcomes of this research are promising, more research is needed to validate this test. Once this is done, early detection of breast cancer will be a cost-effective process that will benefit all patients, especially those in middle and low-income countries. These results have also sparked the interest of researchers to come up with similar methods of early detection in other cancers like lung cancer.
You Might Also Enjoy...
It would be great if we had a crystal ball to tell us which illnesses we’ll get and how to avoid them. Until we do, the next best thing is to know your risk factors for certain diseases, including ovarian cancer.
The calendar says summer’s coming to an end, but here in Texas, it’s summer all year long. That means you’re at high risk for skin cancer unless you take steps to prevent it. Here are five easy ones you can follow year round.
After your breast cancer diagnosis, your mind turns immediately to treatments. You want the most effective, least invasive option possible. Here’s why MammoSite® targeted radiation therapy may be the best answer.
You’d give up almost anything for a chance to beat your cancer. And many treatments will test your resolve to do just that. Hair loss is one of the sacrifices most-often associated with chemo and radiation. Here’s what you can expect.
Three oncology practices with a combined total of ten physicians have recently joined The Center for Cancer and Blood Disorders (The Center), the growing North Texas independent oncology practice, an affiliate of OneOncology, announced today.
Most people are familiar with radiation and chemotherapy as effective go-to treatments, but there are many more cancer-fighting weapons in our arsenal. Here’s how hormone therapy may be a key player in your cancer treatment plan.